Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Fresenius SE & Co. KGaA
  6. Summary
    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
44.94(c) 44.805(c) 45.235(c) 45.27(c) 45.255(c) Last
967 606 1 027 087 983 881 1 074 548 706 541 Volume
+0.26% -0.30% +0.96% +0.08% -0.03% Change
More quotes
Financials
Sales 2021 36 933 M 44 718 M 44 718 M
Net income 2021 1 783 M 2 159 M 2 159 M
Net Debt 2021 22 136 M 26 803 M 26 803 M
P/E ratio 2021 14,1x
Yield 2021 1,89%
Sales 2022 39 081 M 47 319 M 47 319 M
Net income 2022 2 048 M 2 479 M 2 479 M
Net Debt 2022 20 716 M 25 083 M 25 083 M
P/E ratio 2022 12,1x
Yield 2022 2,06%
Capitalization 25 232 M 30 521 M 30 550 M
EV / Sales 2021 1,28x
EV / Sales 2022 1,18x
Nbr of Employees 310 842
Free-Float 73,0%
More Financials
Company
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (48.6%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (32.4%;... 
Read more
More about the company
Ratings of Fresenius SE & Co. KGaA
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about FRESENIUS SE & CO. KGAA
06/10FRESENIUS SE  : Buy rating from Goldman Sachs
MD
06/10PRESS RELEASE : SphingoTec Expands Management Team and Appoints new CFO
DJ
06/09DGAP-DD : Fresenius Medical Care AG & Co. KGaA english
DJ
06/08FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs reiterates its Buy rating
MD
06/02ANALYST RECOMMENDATIONS : Bank of America, Bodycote, Chevron, Dow Inc, Ferguson...
06/01FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies gives a Sell rating
MD
06/01FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs maintains a Buy rating
MD
06/01FRESENIUS SE  : Goldman Sachs reaffirms its Buy rating
MD
05/31FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
05/28FRESENIUS SE & CO. KGAA  : Notification and public disclosure of transactions by..
EQ
05/26DGAP-DD : Fresenius Medical Care AG & Co. KGaA english
DJ
05/26PRESS RELEASE : Immatics Announces Changes to its Board of Directors
DJ
05/25FRESENIUS SE & CO. KGAA  : Dividends
CO
05/24SECTOR UPDATE : Health Care Stocks Still Narrowly Higher in Late Regular-Hours T..
MT
05/24SECTOR UPDATE : Health Care Stocks Higher in Moderation
MT
More news
News in other languages on FRESENIUS SE & CO. KGAA
06/11MILAN STOCK EXCHANGE : Borsa Milano indici quasi fermi, strappano Reno Medici, I..
06/11MÄRKTE EUROPA/Gut behauptet - fallende Renditen stützen
06/10PHARMANUTRA  : firmato accordo per distribuzione SiderAl in Germania
06/09VCI rechnet 2021 nach gutem Auftakt mit stärkerem Wachstum
06/09VCI : Engpässe bei Materialien und Vorprodukten beeinträchtigen bei jedem zweite..
More news
Analyst Recommendations on FRESENIUS SE & CO. KGAA
More recommendations
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 47,60 €
Last Close Price 45,26 €
Spread / Highest target 76,8%
Spread / Average Target 5,17%
Spread / Lowest Target -61,0%
EPS Revisions
Managers and Directors
NameTitle
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Wolfgang Kirsch Chairman-Supervisory Board
Sebastian Biedenkopf Legal, Compliance & Human Resources Director
Klaus-Peter Müller Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO. KGAA19.60%30 521
AIER EYE HOSPITAL GROUP CO., LTD.14.69%55 324
TOPCHOICE MEDICAL CORPORATION39.78%19 369
IHH HEALTHCARE-0.36%11 703
BANGKOK DUSIT MEDICAL SERVICES0.00%11 654
RAMSAY HEALTH CARE LIMITED2.32%11 147